AI speeds discovery, but unclear patent rights for AI-designed drugs threaten exclusivity, returns, and drug-development economics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback